125B11,
fatostatin,
FATOSTATIN,
125256-00-0,
CHEMBL1621019,
Pyridine, 4-[4-(4-methylphenyl)-2-thiazolyl]-2-propyl-,
MLS000332366,
SMR000221636,
2-Propyl-4-(4-p-tolyl-thiazol-2-yl)-pyridine,
125B11,
Oprea1_120708,
AC1LZ122,
SCHEMBL2742732,
BDBM78179,
CHEBI:95052,
cid_2850562,
ZROSUBKIGBSZCG-UHFFFAOYSA-N,
BCP20994,
ZINC2262581,
STK326446,
AKOS005434229,
CS-5810,
MCULE-2869230499,
AJ-34493,
HY-14452,
ST45157155,
2-(2-propyl-4-pyridyl)-4-(p-tolyl)thiazole,
2-(2-propyl-4-pyridyl)-4-(p-tolyl)thiazole;hydrobromide,
4-(4-methylphenyl)-2-(2-propyl(4-pyridyl))-1,3-thiazole,
4-(4-methylphenyl)-2-(2-propylpyridin-4-yl)-1,3-thiazole,
4-[4-(4-methylphenyl)-1,3-thiazol-2-yl]-2-propylpyridine,
4-(4-methylphenyl)-2-(2-propyl-4-pyridinyl)thiazole;hydrobromide,
4-(4-methylphenyl)-2-(2-propylpyridin-4-yl)-1,3-thiazole;hydrobromide,
Fatostatin A,
ZINC02262581,
CID1889993,
C545733,
2-(2-Propylpyridin-4-yl)-4-(p-tolyl)thiazole hydrobromide,